17608-41-2 (( )

5,6-Dihydrocholesterol;5ξ-Cholestan-3β-ol;(3a,5b)-Cholestan-3-ol;(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;5B-cholestan-3A-ol;5b-Cholestanol;5BETA-CHOLESTAN-3ALPHA-OL;5BETA-CHOLESTAN-3A-OL;COPROSTAN-3A-OL;coprosterol;EPICOPROSTANOL;EPICOPROSTEROL;5.alpha.-Dihydrocholesterol;5.alpha.-Cholestanol;AKOS026750629;NSC-18188;3.beta.-Hydroxy-5.alpha.-cholestane;.beta.-Cholestanol;NSC18188;FT-0622895;5alpha-Cholestan-3beta-ol-d7;NSC115568;Cholestan-3.beta.-ol;NS00007777;5?-cholestan-3?-ol;3.beta.-Hydroxycholestane;NSC-115568;CHEBI:143724;FT-0632271;NS00124867;SCHEMBL2608072;3.beta.-Cholestanol;LS-15221;3-[4-(benzyloxy)phenyl]acrylicacid;FT-0603183;84061-69-8;5.alpha.-Cholestan-3.beta.-ol;2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, hydrochloride (1:1);CHOLESTANOL;Cholestan-3-ol,5.alpha.)-;Cholestan-3beta-ol (VAN);DTXSID90884977;17608-41-2;NSC 115568;Cholestan-3-ol, (3.beta.)-;QYIXCDOBOSTCEI-UJOPKFNNSA-N;Cholestan-3-ol, (3beta)-;cholestanol, 5alpha-cholestan-3beta-ol, powder;3beta-Cholestanol;SCHEMBL158868;AI3-52417;5xi-Cholestan-3beta-ol;CHEMBL68951;(3S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;5 alpha Cholestan 3 alpha ol;AKOS015841768;

QYIXCDOBOSTCEI-UJOPKFNNSA-N

1S/C27H48O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h18-25,28H,6-17H2,1-5H3/t19-,20?,21+,22+,23-,24+,25+,26+,27-/m1/s1

O[C@H]1CC[C@@]2(C)C(C1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]21